On May 5, Alan Minsk was featured in the FDAnews Drug Daily Bulletin. The article, “Firms Providing Off-Label Articles Must Stay Mum,” offers guidance to manufacturers on off-label uses of their products. Please click here to view the article.
We welcome your interest in AGG. However, we cannot represent you nor can we treat unsolicited information as confidential until we know that doing so will not create a conflict of interest. Accordingly, please DO NOT send information about any matter unless you have a written engagement letter from us stating that we represent you as a client.